The simultaneous assessment of ANKRD22 and SERPING1 expression demonstrates enhanced predictive capacity for identifying drug resistance, thereby enabling earlier detection and therapeutic intervention in drug-resistant TB. Here, ANKRD22 is linked to tuberculosis.